ResMed Inc.
ResMed Inc.
Your view on RMD
Overview
What the company does, where it operates, and who runs it.
About ResMed Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Michael J. Farrell BE, MBA, SM
- Headquarters
- 9001 Spectrum Center Boulevard, San Diego, CA, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Michael J. Farrell BE, MBA, SM
- Headquarters
- 9001 Spectrum Center Boulevard, San Diego, CA, US
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service.
It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal.
It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies.
The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for ResMed Inc. from FRC's valuation model, read against the market price. RMD last traded at $238.19, 21.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for ResMed Inc.. Starting points for ResMed Inc.: P/E 21.7, EPS $11.14, beta 0.76 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for ResMed Inc.. ResMed Inc. paid $2.52 per share over the last year — a 1.1% yield at the current $238.19 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for ResMed Inc.. Trailing twelve-month EPS for ResMed Inc. stands at $11.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$251.42
average of 12 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy3
- Hold8
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | $2.99 | $3.05 | $12.14 | $13.25 |
| Low estimate | $2.95 | $2.99 | $12.09 | $13.05 |
| High estimate | $3.09 | $3.18 | $12.23 | $13.78 |
| No. of analysts | 9 | 9 | 15 | 14 |
| Year-ago EPS | $2.81 | $2.86 | $10.43 | — |
| Growth | +6.5% | +6.7% | +16.4% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | $1.46B | $1.46B | $5.83B | $6.19B |
| Low estimate | $1.45B | $1.44B | $5.82B | $6.09B |
| High estimate | $1.48B | $1.47B | $5.86B | $6.25B |
| No. of analysts | 10 | 10 | 22 | 21 |
| Year-ago revenue | $1.42B | $1.43B | $5.65B | — |
| Growth | +2.3% | +1.7% | +3.1% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for ResMed Inc.. ResMed Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- BSXBoston Scientific CorporationMedical - Devices$63.3B
- ELMDElectromed, Inc.Medical - Devices$189M
- FSPKFFisher & Paykel Healthcare Corporation LimitedMedical - Instruments & Supplies$14.2B
- GEHCGE HealthCare Technologies Inc.Medical - Devices$37.5B
- GNGBYGetinge AB (publ)Medical - Devices$6.1B
- INSPInspire Medical Systems, Inc.Medical - Devices$1.7B
- ISRGIntuitive Surgical, Inc.Medical - Instruments & Supplies$151.7B
- MDTMedtronic plcMedical - Devices$131.6B
More Medical - Instruments & Supplies companies
- SDMHFSartorius Stedim Biotech S.A.OTC$21.2B
- SHWGFShandong Weigao Group Medical Polymer Company LimitedOTC$3.3B
- ADDLFAddLife AB (publ)OTC$4.9B
- AHC.AXAustco Healthcare LimitedASX
- AHICFAsahi Intecc Co., Ltd.OTC$5.6B
- ANGOAngioDynamics, Inc.NASDAQ$495M
- ANN.AXAnsell LimitedASX
- ANSLFAnsell LimitedOTC$3.3B
- ANSLYAnsell LimitedOTC$3.3B
- ATRAptarGroup, Inc.NYSE$9.1B
- ATRCAtriCure, Inc.NASDAQ$2.8B
- AVTRAvantor, Inc.NYSE$10.4B
ETFs holding ResMed Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.05%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.05%
- VOVanguard Mid-Cap ETF$103.4B in assets0.32%
- IVViShares Core SP 500 ETF$852.9B in assets0.05%
- IHIiShares US Medical Devices ETF$4.0B in assets4.34%
- SEIQSEI Enhanced U.S. Large Cap Quality Factor ETF$782M in assets2.32%
- FTGSFirst Trust Growth Strength ETF$1.2B in assets2.06%
- XOVRERShares Private-Public Crossover ETF$1.4B in assets1.96%
Largest holders first, then the funds most concentrated in RMD.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold ResMed Inc., and how their positions are changing. At a $33.50B market value, institutional positions materially move ResMed Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by ResMed Inc. executives and directors. Shares of ResMed Inc. have traded between $199.92 and $293.81 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming ResMed Inc.. ResMed Inc. is a $33.50B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming ResMed Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for ResMed Inc.. Coverage tracks ResMed Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of ResMed Inc.